What is Nuedexta and what does it cost?
Nuedexta (dextromethorphan hydrobromide and quinidine sulfate) is a prescription medication used to treat pseudobulbar affect (PBA) [1]. PBA is a neurological condition that causes sudden, uncontrollable episodes of laughing or crying [1]. The average retail price for Nuedexta is approximately $751.79 for a 30-day supply of 20 mg-10 mg capsules [2].
How can I get financial assistance for Nuedexta?
Financial assistance programs may be available for eligible patients. Avanir Pharmaceuticals, the manufacturer of Nuedexta, offers the Avanir Patient Access program, which can provide co-pay assistance for commercially insured patients [3]. For uninsured or underinsured patients, there are patient assistance programs that can help reduce the cost of medication [3]. These programs often have specific eligibility requirements based on income and insurance status [3].
What is the typical dosage and supply of Nuedexta?
Nuedexta is typically prescribed as one 20 mg-10 mg capsule taken twice daily [1]. A 30-day supply would therefore consist of 60 capsules [1].
What are the potential side effects of Nuedexta?
Common side effects of Nuedexta include dizziness, cough, urinary tract infection, and falls [1]. It is important to discuss any concerns about side effects with a healthcare provider.
When does Nuedexta's patent protection expire?
Drug patent information can be complex and subject to change. While specific patent expiry dates for Nuedexta are not detailed here, information on drug patents and exclusivity can often be found through resources like DrugPatentWatch.com [4].
---
Sources:
[1] https://www.nuedexta.com/
[2] https://www.goodrx.com/nuedexta
[3] https://www.avanir.com/patients/nuedexta/patient-access/
[4] https://drugpatentwatch.com/